Cogent Biosciences, Inc. (COGT) vs Iovance Biotherapeutics, Inc. (IOVA)
A side-by-side comparison of Cogent Biosciences, Inc. and Iovance Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COGT
Cogent Biosciences, Inc.
$30.25HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
IOVA
Iovance Biotherapeutics, Inc.
$13.24HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — COGT vs IOVA
growth of $100 · dividends reinvested · last 9yCOGT -30.5% (-4.0%/yr)IOVA -16.3% (-2.0%/yr)IOVA compounded faster over this window
COGT IOVA
COGT vs IOVA: by the numbers
- •IOVA is the larger company ($5.91B vs $5.17B market cap).
- •Both run net losses; COGT's is the smaller (0.00% vs -89.09% net margin).
Metrics side by side
Valuation
| Metric | COGT | IOVA |
|---|---|---|
| P/S ratio | N/A | 18.19 |
| P/B ratio | 11.05 | 8.03 |
Profitability
| Metric | COGT | IOVA |
|---|---|---|
| Gross margin | 0.00% | 97.23% |
| Operating margin | 0.00% | -153.08% |
| Net margin | 0.00% | -89.09% |
| ROE | -70.85% | -39.33% |
| ROIC | -50.09% | -37.26% |
Growth (annualized)
| Metric | COGT | IOVA |
|---|---|---|
| Total return CAGR (5Y) | 28.51% | -11.55% |
Frequently asked
- How have COGT and IOVA total returns compared?
- Over the past 5 years, COGT delivered 28.51% and IOVA delivered -11.55% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.